APA (7th ed.) Citation

BA, G., J, G., A, C., S, P., XJ, X., J, Y., . . . J, B. (2015). Prospective evaluation of plasma levels of ANGPT2, TuM2PK, and VEGF in patients with renal cell carcinoma. BMC urology, 15, 24. https://doi.org/10.1186/s12894-015-0019-4

Chicago Style (17th ed.) Citation

BA, Gayed, et al. "Prospective Evaluation of Plasma Levels of ANGPT2, TuM2PK, and VEGF in Patients with Renal Cell Carcinoma." BMC Urology 15 (2015): 24. https://doi.org/10.1186/s12894-015-0019-4.

MLA (9th ed.) Citation

BA, Gayed, et al. "Prospective Evaluation of Plasma Levels of ANGPT2, TuM2PK, and VEGF in Patients with Renal Cell Carcinoma." BMC Urology, vol. 15, 2015, p. 24, https://doi.org/10.1186/s12894-015-0019-4.